| « Previous month | Next month » |
Analytical laboratory LGC has set up an initiative to develop a new approach to training for analysts working in molecular laboratories, with a novel e-learning tool.
GE will drop the CodeLink array system in 2007 and close a US-based production facility.
Thermo Fisher Scientific has bought Cohesive, an advanced sample extraction and liquid chromatography products manufacturer.
The UK's Department of Trade and Industry (DTI) has pledged its support to an ultrasound spectroscopy project conducted by LGC, to evaluate its potential as a Process Analytical Tool (PAT) for non-destructive testing, real time acquisition and potential on-line use.
A breakthrough in diabetes research has finally let scientists answer the elusive question of what causes the disease, enabling them to develop to a new treatment that reverses its effects.
Fluidigm has launched its digital PCR technology, allowing scientists to analyse a single DNA template, which will give them the opportunity to detect cancer much earlier.
In the next one to two years there will be a trend towards significant reductions in clinical outsourcing/contract research organisation (CRO) budgets in the majority of biopharma firms, reveals a recent industry survey.
A UK based firm aims to take up the fight against drug counterfeiters with its innovative imaging and spectroscopy products. TeraView says its technology could aid regulators and law enforcement agencies screen for potentially lethal fake medicines.
New stem cell purification technology allows fast and accurate purification.
MDS has been heavily impacted by a US Food and Drug Administration procedural review of its bioanalytical operations, but still managed to report quarterly earnings of C$53m (€35m).
New technology provides unprecedented opportunities for unbiased pathogen discovery.
Synthetic extra-cellular fluid maintains cell function and life while increasing pre-clinical trial reproducibility.
According to a review of public healthcare funding, the current method of developing drugs is unsustainable and must be updated if the UK is to remain at the forefront of European bioscience.
A recent report points out that while many European market industries are 'missing the boat' on nanotechnology, large cosmetic companies such as L'Oreal are emerging as market leaders in the use of the technology.
Gen-Probe and 3M have teamed up to develop rapid molecular tests food processors can use to ensure the safety of their products, the two companies announced this month.
EU-funded projects devoted to improving food safety and quality are among those showcased by the European Commission yesterday at a conference in Brussels.
British scientists have supported the use of primates in medical research, but only if no alternatives are available.
Michigan-based Albion Advanced Nutrition, who specializes in fortification, has been granted another US patent relating to its mineral amino acid chelate technology.
Biophage will soon release its PDS96 Biosensor, allowing fast and highly cost-efficient early stage pre-clinical screening of drug candidates.
Fine chemicals maker Siegfried Holdings has agreed to sign over part of the production capacity of its Zofingen production plant to US biotech Celgene Corp in a collaboration worth €34.9m.
PerkinElmer strengthens its position in the cell analysis instrumentation market by acquiring Evotec Technologies for approximately €23m.
Using prebiotics as carriers could protect probiotics during processing and storage, as well imparting their own beneficial effects in the finished product, suggests new research from Finland.
The EU yesterday opened a commmunity reference lab for food packaging, part the bloc's plan to ensure the chemicals used in their manufacture do not affect human health.
Galapagos is to spend up to €19.1m to acquire Inpharmatica in order to accelerate their drug discovery capabilities, especially in the early stages of development.
AdvantaPure is claiming to have created the first radio frequency identification (RFID) tag resistant to gamma irradiation.
The dream of personalised medicine has taken another step towards reality as scientists have developed an innovative nanomechanical sensor for detecting disease and observing the body's reaction to treatment.
A handheld sensor under development uses nanoparticles to detect foodborne bacteria in 15 minutes, its inventors claim.
New flow reactor heater allows high-speed, multi-step reactions in front of your eyes allowing users to monitor progress and intervene in case problems to avoid time and reagent waste.
Two Sealed Air Shanklin Omni form fill sealers have been launched in metric and multi language versions, aimed at the European market.
France has placed itself firmly at the forefront of research into personalised medical solutions for cancer, infectious diseases and rare genetic diseases by investing nearly half a billion euros into the ADNA project.
In order to achieve their expected growth, gene expression markets must overcome the technical hurdles that are currently holding them back.
| « Previous month | Next month » |